106 related articles for article (PubMed ID: 8061885)
1. 2',5'-Oligoadenylate synthetase in autoimmune BB rats.
Bonnevie-Nielsen V
Prog Mol Subcell Biol; 1994; 14():198-208. PubMed ID: 8061885
[No Abstract] [Full Text] [Related]
2. Lymphocytic 2',5'-oligoadenylate synthetase is insensitive to dsRNA and interferon stimulation in autoimmune BB rats.
Bonnevie-Nielsen V; Husum G; Kristiansen K
J Interferon Res; 1991 Dec; 11(6):351-6. PubMed ID: 1800583
[TBL] [Abstract][Full Text] [Related]
3. [The dynamics of 2',5'-oligoadenylate synthetase activity in the nuclear and cytoplasmic fractions of human fibroblasts treated by double-stranded RNAs, by their complexes with DEAE-dextran and by type-I recombinant interferons. The ratio of double-stranded RNA-activated and -nonactivated froms of the enzyme].
Sokolova TM; Antonov AIu; Makhov AM
Antibiot Khimioter; 1991 Jun; 36(6):31-5. PubMed ID: 1898186
[TBL] [Abstract][Full Text] [Related]
4. A misaligned double-stranded RNA, poly(I).poly(C12,U), induces accumulation of 2',5'-oligoadenylates in mouse tissues.
Hearl WG; Johnston MI
Biochem Biophys Res Commun; 1986 Jul; 138(1):40-6. PubMed ID: 2427076
[TBL] [Abstract][Full Text] [Related]
5. 2'-5'-Oligoadenylate synthetase is activated by a specific RNA sequence motif.
Kodym R; Kodym E; Story MD
Biochem Biophys Res Commun; 2009 Oct; 388(2):317-22. PubMed ID: 19665006
[TBL] [Abstract][Full Text] [Related]
6. RNA drug therapy acting via the 2-5A synthetase/RNase L pathway.
Suhadolnik RJ; Reichenbach NL; Hitzges PM; Ablashi DV; Strayer DR; Carter WA
Ann N Y Acad Sci; 1993 Jun; 685():756-7. PubMed ID: 8363281
[No Abstract] [Full Text] [Related]
7. The antiviral 2',5'-oligoadenylate synthetase is persistently activated in type 1 diabetes.
Bonnevie-Nielsen V; Martensen PM; Justesen J; Kyvik KO; Kristensen B; Levin K; Beck-Nielsen H; Worsaa A; Dyrberg T
Clin Immunol; 2000 Jul; 96(1):11-8. PubMed ID: 10873423
[TBL] [Abstract][Full Text] [Related]
8. 8-Azido double-stranded RNA photoaffinity probes. Enzymatic synthesis, characterization, and biological properties of poly(I,8-azidoI).poly(C) and poly(I,8-azidoI).poly(C12U) with 2',5'-oligoadenylate synthetase and protein kinase.
Li SW; Moskow JJ; Suhadolnik RJ
J Biol Chem; 1990 Apr; 265(10):5470-4. PubMed ID: 2318823
[TBL] [Abstract][Full Text] [Related]
9. [The activity of 2',5'-oligoadenylate-synthetase in rat spleen lymphocytes in the chronic ethanol intoxication and administration of zinc acetate].
Chaĭka VO; Kompanets' IV; Hadiliia OP; Kharchenko OI; Ostapchenko LI
Ukr Biokhim Zh (1999); 2010; 82(4):100-4. PubMed ID: 21516723
[TBL] [Abstract][Full Text] [Related]
10. Activation of 2'-5' oligoadenylate synthetase by single-stranded and double-stranded RNA aptamers.
Hartmann R; Norby PL; Martensen PM; Jorgensen P; James MC; Jacobsen C; Moestrup SK; Clemens MJ; Justesen J
J Biol Chem; 1998 Feb; 273(6):3236-46. PubMed ID: 9452437
[TBL] [Abstract][Full Text] [Related]
11. Effects of fibroblast and recombinant leukocyte interferons and double-stranded RNA on ppp(2'-5')An synthesis and cell proliferation in human colon carcinoma cells in vitro.
Chapekar MS; Glazer RI
Cancer Res; 1983 Jun; 43(6):2683-7. PubMed ID: 6189584
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune diabetes and the germ theory of disease.
Wilkin TJ
Diabetologia; 1992 Feb; 35(2):187-9. PubMed ID: 1312494
[No Abstract] [Full Text] [Related]
13. Two molecular weight forms of human 2',5'-oligoadenylate synthetase have different activation requirements.
Ilson DH; Torrence PF; Vilcek J
J Interferon Res; 1986 Feb; 6(1):5-12. PubMed ID: 3701128
[TBL] [Abstract][Full Text] [Related]
14. Nonimmunogenic perinatal islets, transplanted intrathymically to BB/Wor recipients, do not prevent onset of autoimmune diabetes.
Ketchum RJ; Mayo G; Park DH; Naji A; Brayman KL
Transplant Proc; 1994 Dec; 26(6):3311-2. PubMed ID: 7998149
[No Abstract] [Full Text] [Related]
15. Comparative study of 2',5'-oligoadenylate (2-5A) synthetase in control and Alzheimer's disease (AD) cells.
An S; Wu JM
Biochem Mol Biol Int; 1994 Apr; 32(6):1003-8. PubMed ID: 8061616
[TBL] [Abstract][Full Text] [Related]
16. Methylxanthine treatment of rats reduces 2,5-oligoadenylate synthesis in liver nuclei.
Liu DK; Owens GF
J Toxicol Environ Health; 1987; 20(4):379-86. PubMed ID: 3560260
[TBL] [Abstract][Full Text] [Related]
17. Differential responsiveness to interferon-alpha in beta-cells and non-beta cells.
Bonnevie-Nielsen V; Buschard K; Dyrberg T
Diabetes; 1996 Jun; 45(6):818-21. PubMed ID: 8635659
[TBL] [Abstract][Full Text] [Related]
18. Interferon-associated lymphocyte 2',5'-oligoadenylate synthetase in acute and chronic viral hepatitis.
Heathcote J; Kim YI; Yim CK; LeBrocq J; Read SE
Hepatology; 1989 Jan; 9(1):105-9. PubMed ID: 2461889
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of the antiretroviral effect of dsRNA.
Müller WE; Ushijima H; Schröder HC
Prog Mol Subcell Biol; 1994; 14():66-88. PubMed ID: 7914807
[No Abstract] [Full Text] [Related]
20. Mechanisms of antiviral action of interferon.
Baglioni C; Nilsen TW
Interferon; 1983; 5():23-42. PubMed ID: 6202642
[No Abstract] [Full Text] [Related]
[Next] [New Search]
